Feng-Mei Zhou

478 total citations
25 papers, 286 citations indexed

About

Feng-Mei Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feng-Mei Zhou has authored 25 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Feng-Mei Zhou's work include MicroRNA in disease regulation (5 papers), Chromium effects and bioremediation (3 papers) and Circular RNAs in diseases (3 papers). Feng-Mei Zhou is often cited by papers focused on MicroRNA in disease regulation (5 papers), Chromium effects and bioremediation (3 papers) and Circular RNAs in diseases (3 papers). Feng-Mei Zhou collaborates with scholars based in China, United States and South Korea. Feng-Mei Zhou's co-authors include Qingwu Wu, Jian-Ge Qiu, Bing‐Hua Jiang, Wenjing Liu, Liu L, Ying Hu, Erjiang Zhao, Yang Rui-min, Ying Hu and Dongming Han and has published in prestigious journals such as British Journal of Pharmacology, European Journal of Pharmacology and Cancer Letters.

In The Last Decade

Feng-Mei Zhou

24 papers receiving 286 citations

Peers

Feng-Mei Zhou

PRM

ONCOL

RNMI

Tianshu Yang China

Haonan Wang China

Xiao Zhou China

Xiaoying Wei China

Zhe Liu China

Yuyang Tian China

Ashwani Tandon India

Yiyang Liu China

Zhongjin Yue China

Tianshu Yang China

Feng-Mei Zhou

123 ×1.0

48 ×0.6

37 ×0.6

PRM

46 ×0.9

ONCOL

36 ×0.9

RNMI

Citations per year, relative to Feng-Mei Zhou Feng-Mei Zhou (= 1×) peers Tianshu Yang

Countries citing papers authored by Feng-Mei Zhou

Since Specialization

Citations

This map shows the geographic impact of Feng-Mei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng-Mei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng-Mei Zhou more than expected).

Fields of papers citing papers by Feng-Mei Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng-Mei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng-Mei Zhou. The network helps show where Feng-Mei Zhou may publish in the future.

Co-authorship network of co-authors of Feng-Mei Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Feng-Mei Zhou. A scholar is included among the top collaborators of Feng-Mei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng-Mei Zhou. Feng-Mei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Jian‐Ge, Peng Sang, Feng-Mei Zhou, et al.. (2025). Novel role of MKRN2 in regulating tumor growth through host microenvironment and macrophage M1 to M2 switch. Cancer Letters. 633. 218035–218035. 1 indexed citations

Wang, Shuai, Yi Ba, Wenjun Liu, et al.. (2025). Differentiating rectal cancer grades using virtual magnetic resonance elastography and fractional order calculus diffusion model. BMC Cancer. 25(1). 734–734. 2 indexed citations

Liu, Wenjing, Lin Wang, Feng-Mei Zhou, et al.. (2024). Hexavalent chromium induced metabolic reprogramming, carcinogenesis and tumor progression through PDK1 upregulation. Ecotoxicology and Environmental Safety. 288. 117341–117341.

Qiu, Jian-Ge, et al.. (2024). Reactive oxygen species mediate ovarian cancer development, platinum resistance, and angiogenesis via CXCL8 and GSK-3β/p70S6K1 axis. Genes & Diseases. 12(2). 101378–101378. 1 indexed citations

Wang, Lin, Peng Sang, Ye Zhang, et al.. (2024). HK2 and LDHA upregulation mediate hexavalent chromium-induced carcinogenesis, cancer development and prognosis through miR-218 inhibition. Ecotoxicology and Environmental Safety. 279. 116500–116500. 8 indexed citations

Zhai, Xiaoyang, Feng-Mei Zhou, Ying Hu, et al.. (2023). Multimodality MRI Radiomics Based on Machine Learning for Identifying True Tumor Recurrence and Treatment-Related Effects in Patients with Postoperative Glioma. Neurology and Therapy. 12(5). 1729–1743. 9 indexed citations

Liu, Wenjing, Lin Wang, Feng-Mei Zhou, et al.. (2023). Elevated NOX4 promotes tumorigenesis and acquired EGFR-TKIs resistance via enhancing IL-8/PD-L1 signaling in NSCLC. Drug Resistance Updates. 70. 100987–100987. 37 indexed citations

Wang, Lin, et al.. (2023). MKRN2 knockout causes male infertility through decreasing STAT1, SIX4, and TNC expression. Frontiers in Endocrinology. 14. 1138096–1138096. 3 indexed citations

Ding, Yi, Zehua Wang, Feng-Mei Zhou, Chen Chen, & Yanru Qin. (2022). Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer. Frontiers in Oncology. 12. 987302–987302. 5 indexed citations

10.

Zhu, Ying, Hongjian Li, Rong Su, et al.. (2021). Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma. Molecular Medicine. 27(1). 15–15. 12 indexed citations

11.

Wang, Lin, Lihong Wang, Jian‐Ge Qiu, et al.. (2020). Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer. Frontiers in Cell and Developmental Biology. 8. 840–840. 10 indexed citations

12.

Wang, Lin, Jian-Ge Qiu, Jun He, et al.. (2019). Suppression of miR-143 contributes to overexpression of IL-6, HIF-1α and NF-κB p65 in Cr(VI)-induced human exposure and tumor growth. Toxicology and Applied Pharmacology. 378. 114603–114603. 28 indexed citations

13.

Li, Qiang, et al.. (2019). LncRNA LINC00319 is associated with tumorigenesis and poor prognosis in glioma. European Journal of Pharmacology. 861. 172556–172556. 40 indexed citations

14.

Qiu, Jian-Ge, Lin Wang, Wenjing Liu, et al.. (2019). Apigenin Inhibits IL-6 Transcription and Suppresses Esophageal Carcinogenesis. Frontiers in Pharmacology. 10. 1002–1002. 36 indexed citations

15.

Zhuang, Yan, et al.. (2018). MicroRNA-337-5p participates in the development and progression of osteosarcoma via ERBB, MAPK and VEGF pathways.. PubMed. 22(17). 5460–5470. 5 indexed citations

16.

Yan, Ruifang, et al.. (2017). Diagnostic value of conventional MRI combined with DTI for neonatal hyperbilirubinemia. Pediatrics & Neonatology. 59(2). 161–167. 8 indexed citations

17.

Yan, Ruifang, Bo Zhang, Long Wang, et al.. (2017). A comparison of contrast-free MRA at 3.0 T in cases of intracranial aneurysms with or without subarachnoid hemorrhage. Clinical Imaging. 49. 131–135. 7 indexed citations

18.

Chen, Jie, et al.. (2015). Comparative analysis between 64- and 320-slice spiral computed tomography in the display of coronary artery stents and diagnosis of in-stent restenosis. Experimental and Therapeutic Medicine. 10(5). 1871–1876. 3 indexed citations

19.

Wu, Qingwu, Yang Rui-min, Feng-Mei Zhou, & Ying Hu. (2013). Comparison of whole-body MRI and skeletal scintigraphy for detection of bone metastatic tumors: A meta-analysis. Surgical Oncology. 22(4). 261–266. 22 indexed citations

20.

Zhou, Feng-Mei. (2005). Several factors affecting sonochemical yield. Shengxue jishu. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact